Meanwhile, another Team Ang Zheng found that SNORA47 affected stemness and chemotherapy sensitivity of Luminal breast cancer cells via EBF3/RPL11/c-Myc axis, providing a new direction for precision therapy of Luminal breast cancer patients (73). This evidence concerns the gene MYC and breast carcinoma.